- Breakthrough designation is based on positive outcomes from clinical studies, and will advance the industry’s first next-generation digital therapeutic to treat memory and cognition in Alzheimer’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback